Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Cancer Medicine|January 17, 2026
Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Cohort StudyNobuhito Taniki, Keisuke Ojiro, Ryosuke Kasuga, et al.
Oncotarget|April 21, 2017
Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinomaMasayuki Yokoyama, Tetsuhiro Chiba, Yoh Zen, et al.
International Cancer Conference Journal|April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinomaHaruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
Liver Cancer|March 27, 2025
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic TherapyMasanori Inoue, Sadahisa Ogasawara, Kazufumi Kobayashi, et al.
JHEP Reports : Innovation in Hepatology|March 29, 2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trialSadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Scientific Reports|May 13, 2024
Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinomaRyosuke Kasuga, Nobuhito Taniki, Po-Sung Chu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 29, 2024
Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysisTomomi Ozaki, Sae Yumita, Sadahisa Ogasawara, et al.
Drugs - Real World Outcomes|July 19, 2023
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective AnalysisHiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, et al.
Liver Cancer|October 21, 2020
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical TrialsKeisuke Koroki, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Liver Cancer|October 1, 2020
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular CarcinomaSusumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Pageof 15